Skip to main content.

Pfizer

Picture of William Heisel

John Carey, a 20-year veteran at BusinessWeek, wrote a story that set the pharmaceutical world on its ear in January 2008. Titled "Do Cholesterol Drugs Do Any Good?," the article systematically broke down the many myths behind the so-called "miracle cure" for heart disease: statins. Carey's story won an award from the Association of Health Care Journalists at its conference in Seattle.

Picture of William Heisel

Six of the world's biggest drug companies are about to be winnowed down to three. If all the mergers go through, we will have Pfizer-Wyeth, Merck-Schering-Plough and Roche-Genentech controlling more than $100 billion in drug sales every year - amounting to one seventh of all revenues for drug companies worldwide. (I wrote a story about this a couple weeks ago for the Los Angeles Times.)

Picture of Andrea Kobrinsky Alday

Journalists have to ask hard questions about where sources get their money – and about the science they are promoting. Following the money trail can be daunting. But journalists and whistleblowers are doing just that and uncovering important connections. Here's what to look for.

Pages

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth